Nouri Alaleh 4

What Happened Nouri Alaleh, EVP, CLO and Corporate Secretary of PROCEPT BioRobotics (PRCT), sold a total of 3,243 shares on March 10, 2026 in open-market transactions. The filings show 3,098 shares disposed at a weighted average price of $25.60 (total $79,320) and 145 shares disposed at a weighted average price of $26.74 (total $3,877), for aggregate proceeds of $83,197. These were sales (not purchases) and were effected pursuant to a prearranged Rule 10b5-1 trading plan.

Key Details

• Transaction date: 2026-03-10; Form 4 filed: 2026-03-12 (timely — within the standard two business days).
• Quantities & prices reported:
  • 3,098 shares at weighted avg $25.60 (per-share range $25.11–$25.96) — footnote F2.
  • 145 shares at weighted avg $26.74 (per-share range $26.365–$26.98) — footnote F3.
• Total shares sold: 3,243; total proceeds reported: $83,197.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Notable footnote: F1 — sales were made under a Rule 10b5-1 trading plan adopted June 4, 2025. F2/F3 note weighted-average pricing and provide ranges; the filer will disclose per-price breakdown on request.

Context Sales executed under a 10b5-1 plan are prearranged and often routine, allowing insiders to trade according to a schedule regardless of subsequent inside information; they do not necessarily indicate a change in the insider’s view of the company. For retail investors, purchases by insiders tend to be more informative about confidence than routine sales; this filing documents scheduled disposition of stock.